AnaptysBio, Inc. Forecast, price target & analysts
AnaptysBio, Inc. Target price 2025 - Analyst rating & recommendation
AnaptysBio, Inc. Classifications & Recommendation:
AnaptysBio, Inc. Price Target
| Target Price | $39.78 |
| Price | $22.47 |
| Potential |
77.04%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target AnaptysBio, Inc. 2026 .
The average AnaptysBio, Inc. target price is $39.78.
This is
77.04%
register free of charge
$94.50
320.56%
register free of charge
$18.18
19.09%
register free of charge
|
|
| A rating was issued by 18 analysts: 14 Analysts recommend AnaptysBio, Inc. to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the AnaptysBio, Inc. stock has an average upside potential 2026 of
77.04%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 91.28 | 66.99 |
| 431.93% | 26.61% | |
| EBITDA Margin | -125.26% | -158.47% |
| 86.26% | 26.51% | |
| Net Margin | -159.10% | -245.43% |
| 83.31% | 54.26% |
13 Analysts have issued a sales forecast AnaptysBio, Inc. 2025 . The average AnaptysBio, Inc. sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an AnaptysBio, Inc. EBITDA forecast 2025. The average AnaptysBio, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 AnaptysBio, Inc. Analysts have issued a net profit forecast 2025. The average AnaptysBio, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -5.12 | -5.41 |
| 15.79% | 5.66% | |
| P/E | negative | |
| EV/Sales | 4.78 |
13 Analysts have issued a AnaptysBio, Inc. forecast for earnings per share. The average AnaptysBio, Inc. EPS is
This results in the following potential growth metrics and future valuations:
AnaptysBio, Inc....
Current AnaptysBio, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jun 04 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | May 28 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | May 06 2025 |
| Wedbush |
Locked
➜
Locked
|
Locked | May 01 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Mar 05 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 04 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Feb 13 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jun 04 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
May 28 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
May 06 2025 |
|
Locked
Wedbush:
Locked
➜
Locked
|
May 01 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Mar 05 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 04 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Feb 13 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
